Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-07 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.610 | -0.090 | 0.5200 | ||||
REV | 1.630M | 76.000K | -1.554M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
BXRX | Baudax Bio | 1.40 | -0.10 | -6.67% | 98.2M |
You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.
Other companies in Baudax Bio’s space includes: Opiant Pharmaceuticals (NASDAQ:OPNT), Cumberland (NASDAQ:CPIX) and Cocrystal Pharma (NASDAQ:COCP).
The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Oppenheimer on 2020-05-11. The analyst firm set a price target for 14.00 expecting BXRX to rise to within 12 months (a possible 900.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Baudax Bio (NASDAQ: BXRX) is $1.4 last updated Thu Feb 25 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Baudax Bio.
There is no upcoming split for Baudax Bio.